Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical giant (by 0.5%) on Wednesday, leaving several rivals in the dust. These included device makers ResMed (NYSE: RMD) , whose stock suffered a 6% blow, and AdaptHealth (NASDAQ: AHCO) , with a nearly 2% decline. One very useful molecule Before market open, Eli Lilly announced that its molecule tirzepatide had achieved its primary endpoints in a set of phase 3 clinical trials. The studies aimed to judge its efficacy in treating obstructive sleep apnea (OSA), a common disorder in which people struggle to breathe properly while asleep. The company said that tirzepatide had been shown to significantly reduced the apnea-hypopnea index (AHI) compared to a placebo. The AHI, which measures how frequently a patient's breathing is restricted or blocked, is considered an important measure of the condition's severity. Tirzepatide is the basis for Mounjaro and Zepbound, the pha
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why ResMed (RMD) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.MarketBeat
- Why ResMed Stock Is Soaring Today [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 4/25/24 - Beat
RMD
Sec Filings
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- 4/29/24 - Form 144
- RMD's page on the SEC website